Episode Details

Cannabis Investing Guide: Individual Stocks vs. ETFs

We've spent the last couple of episodes looking under the hood of MSOS.

We learned that MSOS isn't simply a basket of cannabis stocks.

We looked at the financial plumbing—total return swaps, counterparties, collateral, tracking differences, and the federal restrictions that helped create this unusual structure.

Now it's time for the bigger question:

If you want exposure to the cannabis industry, should you buy MSOS—or should you buy the individual companies yourself?

That's what we're tackling in this episode of Trail Boss Radio.

🌿 Buy the Team or Scout the Players?

Think about it like baseball.

You can buy the team.

Or you can study the players and decide who deserves a spot on your roster.

MSOS is closer to buying the team.

Individual MSO stocks let you scout the players.

Neither approach automatically wins.

They simply give you different responsibilities, different risks, and different levels of control.

🐂 MSOS: Buy the Basket

MSOS offers a simple way to obtain exposure to the U.S. cannabis sector through one exchange-listed ticker.

Instead of researching and purchasing a collection of individual operators yourself, the ETF handles the portfolio construction and rebalancing.

That can make it easier for an investor who wants sector exposure without spending hours studying every company.

But convenience comes with a price.

There is an annual expense ratio.

There is the ETF's swap structure.

And there are structural risks that come with synthetic exposure.

The Notebook research identifies MSOS's total-return-swap structure as one of the major differences between the ETF and direct stock ownership.

🎯 Individual Stocks: Pick Your Players

Buying an individual MSO is a completely different game.

You actually own shares of the company.

That means direct equity ownership and shareholder rights—but it also means you own the company's problems right alongside its opportunities.

If management makes a bad decision, the stock can suffer.

If debt gets out of control, the stock can suffer.

If dilution occurs, the stock can suffer.

If a particular state market turns ugly, the stock can suffer.

And unlike MSOS, you don't get the protection of spreading your exposure across a basket of companies.

The reward?

Control.

You get to decide which businesses make your roster.

💰 Don't Forget the Cost of Convenience

One of the most interesting comparisons is cost.

MSOS charges an annual expense ratio.

Individual stocks generally don't have an annual management fee simply for holding them.

But there's another cost that doesn't show up on a brokerage statement:

Your time.

If you build your own cannabis portfolio, you've got homework.

You need to read financial statements.

Watch cash flow.

Monitor debt.

Track dilution.

Understand state markets.

Follow federal policy.

And keep an eye on what management is actually doing.

The Notebook research estimates a meaningful monthly time commitment for investors who want to actively monitor a direct portfolio.

So the real comparison isn't simply:

“ETF fee vs. no ETF fee.”

It's also:

“How much am I willing to pay in money—or time—to manage this exposure?”

⚠️ The Liquidity Lesson

Here's another important difference.

MSOS trades on a major exchange.

Many U.S. plant-touching MSOs trade primarily through OTC markets.

That can mean wider spreads and more difficult execution for individual investors.

The sources also point out that MSOS has an options market, while individual OTC cannabis companies generally don't have the same practical options access.

That matters because liquidity i